Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors

Objective: to study the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases type II inhibitors and ability of imatinib to enhance GISTs sensitivity to the chemotherapeutic drugs indicated above.Subjects and Methods. We studied the sensitivity of gastrointestinal stromal tumo...

Full description

Bibliographic Details
Main Authors: S. V. Boichuk, A. R. Galembikova, B. R. Ramazanov, A. Duensing
Format: Article
Language:Russian
Published: ABV-press 2015-06-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/7

Similar Items